Cargando…
A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
We present a case of a 54-year-old Japanese woman with established human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy who developed a refractory infected lung bulla and lung abscess caused by Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Aspergillusspecies. S...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668043/ https://www.ncbi.nlm.nih.gov/pubmed/34934596 http://dx.doi.org/10.7759/cureus.20333 |
_version_ | 1784614486805577728 |
---|---|
author | Sugahara, Kaho Yanagihara, Toyoshi Nakamura, Yuri Nakayama, Yuuka Hanaoka, Katsuzo Ohgushi, Migiwa Ogo, Naruhiko Inutsuka, Yu Asoh, Tatsuma Harada, Yukiko Yoneda, Reiko Maeyama, Takashige |
author_facet | Sugahara, Kaho Yanagihara, Toyoshi Nakamura, Yuri Nakayama, Yuuka Hanaoka, Katsuzo Ohgushi, Migiwa Ogo, Naruhiko Inutsuka, Yu Asoh, Tatsuma Harada, Yukiko Yoneda, Reiko Maeyama, Takashige |
author_sort | Sugahara, Kaho |
collection | PubMed |
description | We present a case of a 54-year-old Japanese woman with established human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy who developed a refractory infected lung bulla and lung abscess caused by Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Aspergillusspecies. Since antibiotic treatment alone failed to resolve the infection, percutaneous drainage of the infected bulla was performed. Although a prolonged treatment period was necessary, the infected lung bulla and the lung abscess were eventually resolved. During her illness, the patient also developed arthritis, possibly related to the HTLV-1 infection. Thus, persons infected with HTLV-1 can develop refractory infections, myelopathy, and arthritis. Percutaneous drainage is an option to treat refractory infected lung bullae. |
format | Online Article Text |
id | pubmed-8668043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-86680432021-12-20 A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy Sugahara, Kaho Yanagihara, Toyoshi Nakamura, Yuri Nakayama, Yuuka Hanaoka, Katsuzo Ohgushi, Migiwa Ogo, Naruhiko Inutsuka, Yu Asoh, Tatsuma Harada, Yukiko Yoneda, Reiko Maeyama, Takashige Cureus Allergy/Immunology We present a case of a 54-year-old Japanese woman with established human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy who developed a refractory infected lung bulla and lung abscess caused by Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Aspergillusspecies. Since antibiotic treatment alone failed to resolve the infection, percutaneous drainage of the infected bulla was performed. Although a prolonged treatment period was necessary, the infected lung bulla and the lung abscess were eventually resolved. During her illness, the patient also developed arthritis, possibly related to the HTLV-1 infection. Thus, persons infected with HTLV-1 can develop refractory infections, myelopathy, and arthritis. Percutaneous drainage is an option to treat refractory infected lung bullae. Cureus 2021-12-10 /pmc/articles/PMC8668043/ /pubmed/34934596 http://dx.doi.org/10.7759/cureus.20333 Text en Copyright © 2021, Sugahara et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Allergy/Immunology Sugahara, Kaho Yanagihara, Toyoshi Nakamura, Yuri Nakayama, Yuuka Hanaoka, Katsuzo Ohgushi, Migiwa Ogo, Naruhiko Inutsuka, Yu Asoh, Tatsuma Harada, Yukiko Yoneda, Reiko Maeyama, Takashige A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy |
title | A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy |
title_full | A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy |
title_fullStr | A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy |
title_full_unstemmed | A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy |
title_short | A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy |
title_sort | refractory, infected lung bulla and an abscess treated using percutaneous drainage in a patient with human t-lymphotropic virus type 1-associated myelopathy |
topic | Allergy/Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668043/ https://www.ncbi.nlm.nih.gov/pubmed/34934596 http://dx.doi.org/10.7759/cureus.20333 |
work_keys_str_mv | AT sugaharakaho arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT yanagiharatoyoshi arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT nakamurayuri arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT nakayamayuuka arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT hanaokakatsuzo arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT ohgushimigiwa arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT ogonaruhiko arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT inutsukayu arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT asohtatsuma arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT haradayukiko arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT yonedareiko arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT maeyamatakashige arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT sugaharakaho refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT yanagiharatoyoshi refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT nakamurayuri refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT nakayamayuuka refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT hanaokakatsuzo refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT ohgushimigiwa refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT ogonaruhiko refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT inutsukayu refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT asohtatsuma refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT haradayukiko refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT yonedareiko refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy AT maeyamatakashige refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy |